Form PREM14A - Preliminary proxy statements relating to merger or acquisition:
SEC Accession No. 0001731122-23-002285
Filing Date
2023-12-22
Accepted
2023-12-22 17:25:55
Documents
9
Period of Report
2023-12-22

Document Format Files

Seq Description Document Type Size
1 PREM14A e5257_prem14a.htm PREM14A 2676505
2 EXHIBIT 107 e5257_ex107.htm EX-FILING FEES 15835
3 GRAPHIC image_004.jpg GRAPHIC 197460
4 GRAPHIC image_005.jpg GRAPHIC 29410
5 GRAPHIC image_006.jpg GRAPHIC 29143
6 GRAPHIC image_007.jpg GRAPHIC 24137
7 GRAPHIC image_008.jpg GRAPHIC 24451
8 GRAPHIC proxy_1.jpg GRAPHIC 668396
9 GRAPHIC proxy_2.jpg GRAPHIC 1251879
  Complete submission text file 0001731122-23-002285.txt   5758555
Mailing Address CENTURY CITY MEDICAL PLAZA 2080 CENTURY CITY EAST SUITE 906 LOS ANGELES CA 90067
Business Address CENTURY CITY MEDICAL PLAZA 2080 CENTURY CITY EAST SUITE 906 LOS ANGELES CA 90067 45 39179840
RENOVARO BIOSCIENCES INC. (Filer) CIK: 0001527728 (see all company filings)

EIN.: 452259340 | State of Incorp.: DE | Fiscal Year End: 0630
Type: PREM14A | Act: 34 | File No.: 001-38758 | Film No.: 231510893
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)